Alvogen Korea Co., Ltd.

Alvogen Korea Co., Ltd.

Alvogen Korea Co., Ltd.

Overview
Date Founded

1958

Headquarters

13/F, IFC Two,10 Kukje Kumyung-ro,Yeouido-dong, Yeongdeungpo-gu,Seoul 07241

Type of Company

Public

Employees (Worldwide)

746

Industries

Pharmaceuticals

Company Description

Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions. The company was founded on January 7, 1958 and is headquartered in Seoul, South Korea.

Executives & Employees

Chief Executive Officer & Director

MD, Head-Research & Development Center

Auditor

Director & Managing Director

Professional

Professional

Professional

Board of Directors

Professional at Lotus Pharmaceutical Co., Ltd. - Taiwan

Strategic Development at Alvogen, Inc.

Chief Executive Officer & Director at Alvogen Korea Co., Ltd.

Director at Alvogen Korea Co., Ltd.

Director & Managing Director at Alvogen Korea Co., Ltd.

Professor at Korea University

Independent Director at Alvogen Korea Co., Ltd.

Paths to Alvogen Korea Co., Ltd.
Potential Connections via
Relationship Science
You
Alvogen Korea Co., Ltd.
Recent Transactions
Details Hidden

Lotus Pharmaceutical Co., Ltd. - Taiwan, Alvogen Korea Holdings Ltd. purchase Alvogen Korea Co., Ltd.

Details Hidden

Alvogen Korea Co., Ltd., Alvogen Korea Holdings Ltd. purchase Dream Pharma Corp. /Pharmaceutical Business from Hanwha Corp.

Details Hidden

Alvogen Korea Co., Ltd. purchases Kukje Hwaje Insurance Co. from Korea Deposit Insurance Corp.

Clients

Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. It establishes and coordinates business strategies for Green Cross subsidiaries that launch business and investment portfolio management. Its products include prescription drugs such as blood derivatives, cerebrovascular disease treatment, fibrinolytic agent, vaccines, hunter syndrome drug, herbal medicine, and recombinant. It also offers over the counter drugs such as skin disease treatment and topical NSAIDs. The company was founded on October 5, 1967 and is headquartered in Yongin, South Korea.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood products, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin-si, South Korea.

Key Stats and Financials As of 2017
Market Capitalization
$307B
Total Enterprise Value
$349B
Earnings Per Share
$909
Revenue
$190B
Net Profit
$10.4B
EBITDA
$32.6B
EBITDAMargin
17.18%
Total Debt
$76.6B
Total Equity
$175B
Enterprise Value Sales
1.84x
Enterprise Value EBITDAOperating
10.68x
TEVNet Income
33.54x
Debt TEV
0.22x
Three Year Compounded Annual Growth Rate Of Revenue
42.8%
Five Year Compounded Annual Growth Rate Of Revenue
23.74%
Suppliers
Kowa Co., Ltd. Equipment & Office Supplies | Nagoya, AI

Kowa Co., Ltd. engages in trading business. Its focus is on trading of textiles, machinery and construction materials, medicines, medical equipment, and energy-saving products. The firm operates through the following business divisions: Pharmaceutical, Life Science, Environmental and Energy Saving Products, Industrial and Infrastructures, Chemical and Food, Lifestyle Business, Information System Solution, and Hospitality. The company was founded in 1894 and is headquartered in Nagoya, Japan.

Roche Holding AG Medical Support Services | Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Hanseo Chemical Co., Ltd. Industrial Machinery & Manufacturing

Hanseo Chemical Co., Ltd. is a South Korean private company that manufactures turbines.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Alvogen Korea Co., Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Alvogen Korea Co., Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Alvogen Korea Co., Ltd..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/alvogen-korea-co-ltd-277710
  • https://relationshipscience.com/organization/alvogen-korea-co-ltd-277710